Anaheim, CA – October 28, 2025 – LiveWire Ergogenics Inc. (OTC: LVVV) today announces the acquisition of a majority equity position in Botanical Intelligence, LLC. This strategic move marks a pivotal expansion of LiveWire’s botanical wellness business model, reinforcing its commitment to developing and delivering innovative wellness solutions to a rapidly growing market.

Leadership Perspective

Bill Hodson, CEO of LiveWire Ergogenics, Inc., commented on the acquisition: “The acquisition of a majority stake in Botanical Intelligence, LLC aligns perfectly with our wellness business model, with a focus on bringing exceptional products to both the general and specialty wellness markets. We are looking forward to partnering with Botanical to support them in further advancing the development of their unique ‘Omega 3 Ingraining’ technology, tailor-made to accelerate our efforts for the expansion into the broader general wellness market. This partnership is expected to accelerate growth, diversify revenue streams, and enhance long-term shareholder value. ”

For the first time, the Botanical Intelligence™ development is on the path to bring plant-based Omega-3s into the food and beverage market, with no fish or marine source. Omega-3 fatty acids are polyunsaturated fats (or “healthy fats”) that must be derived from foods or supplements. Omega-3 keeps your heart, lungs, and blood vessels intact, fights cardiovascular disease, and keeps the immune system working at an optimal level.

The Botanical Intelligence breakthrough engraining process enables Omegas to provide a “smell-free” solution, which will provide an invaluable competitive marketing advantage to Fortune 500 companies. Botanical has a breakthrough patent in progress that engrains Omegas through a non-marine process, while at the same time saving the planet from overfishing, over pollution, high mercury levels, and avoiding microplastics.

Botanical is continuing the development of nutraceutical grains and seeds using its unique, breakthrough ingredient technology. This technology,  ​initially developed in partnership with the research department of the University of Vermont, aims to produce whole grains and seeds containing all three bioavailable omega-3 EFAs, with the highest standards for safety, stability, and sensory olfaction and taste. The Company’s “Ingraining” technology has the unique ability to release all Omega-3 in one seed (EPA, DHA, and ALA) sourced from an infinitely available, sustainable, and considerably less expensive plant-based solution. The Company’s Ingraining Process creates a superfood, a bioavailable vegan source of Omega-3s, which also enhances the benefits of phytocannabinoids in hemp. The patented process reduces the overfishing of oceans, is derived from plants with no heavy metals or ocean-borne contaminants and provides an invaluable competitive marketing advantage to any company licensing and applying this process to their own products. The original patent has been granted to Botanical and is currently in the renewal and extension stage.

Mr. Hodson added. ” Given the recent Farm Bill passage, the hemp industry, which includes food, beverage, supplements, and CBD products, is currently exploding. ​ The hemp plant is known for its EFA content, and with BI™’s unique technology, we will be able to create seeds with improved bioavailability of EFAs. This will greatly and naturally enhance the benefits of phytocannabinoid compounds, expand our own SOL VIDA product portfolio, license the process to third parties, and accelerate the development of new wellness products at our  Botanical Laboratory. By focusing on unique and branded business-to-business and consumer packaged retail products, non-cannabinoid formulations, and custom white label products for third parties, we can better control pricing, strengthen sales forecasting for Livewire, and ultimately deliver greater long-term value to our shareholders.”

Growth Opportunities

• Market Expansion: The acquisition positions LiveWire to capitalize on the rapidly growing demand for plant-based nutraceuticals and wellness products.

• Proprietary Technology: Botanical Intelligence’s ingraining process produces grains and seeds containing all three essential omega-3 fatty acids (EPA, DHA, and ALA), with superior safety, stability, and taste.

• Sustainability: The technology supports environmental stewardship by reducing overfishing and eliminating ocean-borne contaminants.

• Licensing Potential: LiveWire intends to license this technology to third parties, opening new revenue channels and strengthening its competitive position.

Looking Ahead

This acquisition is part of our expanded business model, which is designed to diversify Livewire’s business beyond cultivation to generate new revenue streams. Beyond its SOL VIDA products and other branded products, LiveWire intends to pursue custom white label partnerships, offering private-label solutions for other companies and opening multiple new revenue streams within the growing wellness sector.

About LiveWire Ergogenics Inc.

LiveWire (the “Company”) is dedicated to building long-term shareholder value by developing and marketing innovative business-to-business and consumer-packaged wellness products that meet the increasing demand for healthier and unique lifestyle solutions. The Company’s portfolio, which includes its SOL VIDA and Estrella Health & Wellness brands, features a broad range of customized general wellness solutions as well as hemp-derived formulations and select THC- and CBD-based products where permitted by law. LiveWire distributes its products through licensed partners, retail networks, and direct-to-consumer channels across the U.S., depending on product configuration. By expanding its footprint in the rapidly growing wellness sector, the Company aims to capture significant market opportunities while maintaining strict regulatory compliance and transparency. For further information, visit www.livewireergogenics.com.

Forward-Looking Statements

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. Such statements are based on current expectations, estimates, and assumptions and are subject to risks and uncertainties that may cause actual results to differ materially from those expressed or implied. Forward-looking statements include, but are not limited to, predictions or expectations regarding the Company’s future performance, product development, business strategy, or potential distribution opportunities. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only valid as of the date of this release. Factors that could cause actual results to differ materially include those described in this release, in the Company’s communications, and in its filings with the Securities and Exchange Commission (“SEC”). Unless otherwise required by law, the Company does not undertake any obligation to revise or update any forward-looking statements.

Contact Information

• Distributor Inquiries: Email: info@livewireergogenics.com

• Investor Relations: Tristan Cavato, ir@livewireergogenics.com

• Market Awareness: Stockwatchindex, LLC, 442-287-8059, www.stockwatchindex.com, admin@stockwatchindex.com

For more information about LiveWire Ergogenics, visit: www.livewireergogenics.com